×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
ERNA – eterna therapeutics inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
ERNA
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/14
08:42 am
erna
Eterna Therapeutics Regains Compliance with NASDAQ for Continued Listing [Yahoo! Finance]
Low
Report
Eterna Therapeutics Regains Compliance with NASDAQ for Continued Listing [Yahoo! Finance]
11/14
08:30 am
erna
Eterna Therapeutics Regains Compliance with NASDAQ for Continued Listing
Medium
Report
Eterna Therapeutics Regains Compliance with NASDAQ for Continued Listing
10/30
08:30 am
erna
Eterna Therapeutics Completes Strategic Financial Restructuring with the Aim to Accelerate its Developmental Activities and Long-Term Success
Medium
Report
Eterna Therapeutics Completes Strategic Financial Restructuring with the Aim to Accelerate its Developmental Activities and Long-Term Success
10/17
08:22 am
erna
Factor Bioscience and Eterna Therapeutics Announce Exclusive License and Collaboration Agreement to Accelerate Cell Therapy Development for Oncology, Autoimmune, and Rare Diseases [Yahoo! Finance]
High
Report
Factor Bioscience and Eterna Therapeutics Announce Exclusive License and Collaboration Agreement to Accelerate Cell Therapy Development for Oncology, Autoimmune, and Rare Diseases [Yahoo! Finance]
10/17
08:00 am
erna
Eterna Therapeutics and Factor Bioscience Announce Exclusive License and Collaboration Agreement to Accelerate Cell Therapy Development for Oncology, Autoimmune, and Rare Diseases
Medium
Report
Eterna Therapeutics and Factor Bioscience Announce Exclusive License and Collaboration Agreement to Accelerate Cell Therapy Development for Oncology, Autoimmune, and Rare Diseases
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/18
04:16 pm
erna
Form 424B3 Eterna Therapeutics Inc.
Low
Report
Form 424B3 Eterna Therapeutics Inc.
11/18
04:16 pm
erna
Form 424B3 Eterna Therapeutics Inc.
Low
Report
Form 424B3 Eterna Therapeutics Inc.
11/18
04:16 pm
erna
Form 424B3 Eterna Therapeutics Inc.
Low
Report
Form 424B3 Eterna Therapeutics Inc.
11/18
07:30 am
erna
Form EFFECT Eterna Therapeutics Inc.
Medium
Report
Form EFFECT Eterna Therapeutics Inc.
11/14
06:46 am
erna
Form D Eterna Therapeutics Inc.
Medium
Report
Form D Eterna Therapeutics Inc.
11/14
06:46 am
erna
Form D Eterna Therapeutics Inc.
Medium
Report
Form D Eterna Therapeutics Inc.
11/12
05:17 pm
erna
Form 10-Q Eterna Therapeutics Inc. For: Sep 30
High
Report
Form 10-Q Eterna Therapeutics Inc. For: Sep 30
11/5
04:31 pm
erna
Form S-1 Eterna Therapeutics Inc.
Medium
Report
Form S-1 Eterna Therapeutics Inc.
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: